Clinical Conversation: SCAI Position Statement on Transcatheter Occlusion of Patent Ductus Arteriosus in Premature Infants-Clinical Conversation: SCAI Position Statement on Transcatheter Occlusion of Patent Ductus Arteriosus in Premature Infants

Clinical Conversation: SCAI Position Statement on Transcatheter Occlusion of Patent Ductus Arteriosus in Premature Infants

Back to course

Video Transcription

Video Summary

This episode of "Conversations in International Cardiology" discusses the SCI Position Statement on transcatheter occlusion of patent ductus arteriosus (PDA) in premature infants. The panel, led by interventional cardiologists and neonatologists, reviews the clinical challenges of managing PDA—a common issue in extremely premature infants linked to respiratory and intestinal complications. Traditionally treated with medication or surgery, PDA closure has shifted following FDA approval in 2019 of a transcatheter device for very low birth weight infants, offering a less invasive option.<br /><br />Key aspects include patient selection, procedural checklists emphasizing safety and efficiency, operator training standards, and institutional infrastructure requirements. The procedure demands multidisciplinary collaboration, meticulous preparation, and careful post-procedure follow-up to monitor complications such as vascular stenosis.<br /><br />The discussion highlights the neonatologists’ pivotal gatekeeper role in deciding when to close a PDA, given the ongoing lack of randomized controlled trials definitively proving benefits of catheter closure over conservative management or pharmacotherapy. The group stresses the need for high-quality evidence and shared decision-making among clinicians and families.<br /><br />Finally, the panel debates technical details like heparin use during the procedure, addressing thrombus risks and bleeding concerns. They acknowledge the evolving procedural experience and encourage outcome tracking to improve safety and efficacy in this vulnerable population.

Asset Caption

closed captions are AI-generated

Keywords

transcatheter occlusion

patent ductus arteriosus

premature infants

interventional cardiology

neonatology

FDA approval 2019

multidisciplinary collaboration

patient selection